Efficacy of a new intravenous β2-adrenergic agonist (bedoradrine, MN-221) for patients with an acute exacerbation of asthma

Respiratory Medicine
Stacey L HouseLawrence M Lewis

Abstract

Many patients with acute exacerbation of asthma are non-responders to inhaled β-adrenergic agonists. The goal of this study was to evaluate the safety and efficacy of intravenous bedoradrine (MN-221), a highly selective β2-adrenergic agonist, as adjunct to standard therapy in the management of patients with acute exacerbation of asthma who did not respond to standard therapy. Patients (N = 167) received standard therapy and were randomized to either bedoradrine (1200 μg) or placebo. Safety and efficacy parameters were monitored hourly for 3 h, followed by a 24-h follow-up visit and an 8-day follow-up phone call. Change in %FEV1 from baseline to Hour 3 was the primary outcome. Secondary outcome measures included change in %FEV1 at 1 and 2 h, change in dyspnea score at 1, 2, and 3 h, treatment failure rate, defined as a combination of hospitalization on the index visit or return to the emergency department within 1 week, and safety monitoring. There was no significant difference in %FEV1 at 3 h between the 2 groups. The dyspnea scores were significantly improved for patients treated with bedoradrine compared to placebo (AUC0-2 hP < 0.005, AUC0-3 hP < 0.05). The safety profile for those treated with bedoradrine was consistent with...Continue Reading

References

Jul 1, 1990·The American Review of Respiratory Disease·J B WasserfallenC H Perret
Aug 13, 1988·BMJ : British Medical Journal·B CheongM J Ward
Jun 1, 1994·American Journal of Respiratory and Critical Care Medicine·S SalmeronG Simonneau
Feb 1, 1997·American Journal of Respiratory and Critical Care Medicine·L StraussE R McFadden
Jun 6, 2000·Journal of Emergency Nursing : JEN : Official Publication of the Emergency Department Nurses Association·K R KendrickR M Smith

❮ Previous
Next ❯

Citations

Nov 27, 2019·Pharmacological Reviews·Stacy Gelhaus WendellCheng Zhang
Aug 9, 2020·The Cochrane Database of Systematic Reviews·Simon S CraigCarole Lunny
Nov 21, 2020·Journal of Medicinal Chemistry·Gang XingMao-Sheng Cheng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

The New England Journal of Medicine
Hector G OrtegaMENSA Investigators
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
Claudia R MorrisDeborah M Gurner
© 2021 Meta ULC. All rights reserved